Ajanta Pharma Surges: Q3 FY26 Revenue Jumps 20% on Strong Brand Performance and New Product Success
Ajanta Pharma Ltd. reported outstanding financial results. The company achieved significant growth in the third quarter of fiscal year 2026. This performance highlights its robust business strategy. Financial Highlights for Q3 FY26 Revenue from operations reached INR 1,375 crore. This marks a strong 20% increase compared to the previous year. For the first nine months…

